The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Johnson & Johnson shares valued at $1,160,994 were sold by Decker Robert J on Feb 25 ’25. At $165.88 per share, Decker Robert J sold 6,999 shares. The insider’s holdings dropped to 21,001 shares worth approximately $3.24 million following the completion of this transaction.
Also, Decker Robert J purchased 6,999 shares, netting a total of over 1,161,010 in proceeds.
Before that, Schmid Timothy had sold 403 shares from its account. In a trade valued at $62,928, the EVP, WW Chair, MedTech traded Johnson & Johnson shares for $156.15 each. Upon closing the transaction, the insider’s holdings decreased to 403 shares, worth approximately $2.33 million.
Analysts at Wolfe Research started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid November. As of July 23, 2024, Daiwa Securities has decreased its “an Outperform” rating to a “Neutral” for JNJ.
Analyzing JNJ Stock Performance
During the last five days, there has been a drop of approximately -0.30%. Over the course of the year, Johnson & Johnson shares have jumped approximately 6.80%. Shares of the company reached a 52-week high of $169.99 on 03/04/25 and a 52-week low of $140.68 on 01/10/25. A 50-day SMA is recorded $159.73, while a 200-day SMA reached $157.11.
Support And Resistance Levels for Johnson & Johnson (JNJ)
According to the 24-hour chart, there is a support level at 153.52, which, if violated, would cause prices to drop to 152.58. In the upper region, resistance lies at 155.24. The next price resistance is at 156.03. RSI (Relative Strength Index) is 45.69 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.37, which suggests the price will decrease in the coming days. Percent R is at 44.27%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
